FDA Adverse Event Injury Summary report: N

INTEGRA¿ FLOWABLE WOUND MATRIX

MDR report key: 14718958 · Received June 16, 2022

Report

Report Number
1121308-2022-00037
Event Type
Injury
Date Received
June 16, 2022
Date of Event
April 28, 2022
Report Date
July 27, 2022
Manufacturer
INTEGRA LIFESCIENCES CORPORATION
Product Code
KGN
PMA / PMN Number
K072113
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AN INVESTIGATION HAS BEEN INITIATED BASED ON THE REPORTED INFORMATION. UPON COMPLETION OF THE INVESTIGATION, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION RECEIVED: TREATMENT WAS DIFFICULT FOR THE PATIENT; ONE WEEK AT THE HOSPITAL; 8 DAYS WITH LINEZOLIDE AT HOME WHICH MADE HER SICK AND PERFUSION OF IRON.

Additional Manufacturer Narrative · 0

COMPLAINT SAMPLE WAS NOT RETURNED FOR EVALUATION; THEREFORE, AN EVALUATION OF THE DEVICE COULD NOT BE PERFORMED. LOT NUMBER INFORMATION HAS BEEN PROVIDED; THEREFORE, MANUFACTURING RECORDS WERE REVIEWED AND FOUND NO ANOMALIES. THE CAUSE(S) OF THE DIFFICULTY REPORTED BY THE CUSTOMER COULD NOT BE DETERMINED. IF ADDITIONAL RELEVANT INFORMATION BECOMES AVAILABLE IN THE FUTURE, THIS COMPLAINT WILL BE REOPENED, AND THE RESPECTIVE EVALUATION PERFORMED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR ISSUES. AT PRESENT, WE CONSIDER THIS COMPLAINT TO BE CLOSED. IT SHOULD BE NOTED THAT WHILE CORYNEBACTERIUM BOVIS IS OFTEN RECOVERED FROM COWS, THE MAIN RESERVOIR FOR THESE ORGANISMS WOULD BE INFECTED UDDERS AND TEAT DUCTS OF THE COWS. CONVERSELY, THE SOURCE FOR THE COLLAGEN UTILIZED IN THE FLOWABLE WOUND MATRIX PRODUCT IS BOVINE TENDON. THESE ARE TWO PORTIONS OF THE COW ARE NOT ONLY SEPARATED GEOGRAPHICALLY BUT ONE OF THE ORGANS IS EXTERNAL TO THE MAIN BODY AND THE COW AND THE OTHER IS INTERNAL. CONSEQUENTLY, IT IS UNLIKELY THAT AN ORGANISM WHICH COLONIZES THE UDDERS OF COWS WOULD BE TRANSFERRED TO THE BOVINE TENDONS IN SUFFICIENT QUANTITIES TO SURVIVE THE ALL THE AFOREMENTIONED BACTERIAL REDUCTION STAGES IN THE MANUFACTURE OF THESE MEDICAL DEVICES. ADDITIONAL INFORMATION RECEIVED: ISSUE HAS BIG IMPACT ON PROFESSIONAL LIFE OF THE PATIENT. TREATMENT WAS DIFFICULT FOR THE PATIENT: ONE WEEK AT HOSPITAL; 8 DAYS WITH LINEZOLIDE AT HOME WHICH MADE HER SICK; PERFUSION OF IRON.

Description of Event or Problem · 0

A PHYSICIAN REPORTED INFECTION WITH CORYNEBACTERIUM BOVIS ON THE SITE THE WOUND MATRIX WAS PLACED. THE MATRIX WAS PLACED ON PATIENT'S FACE ON (B)(6) 2022 AND THE INFECTION WAS DETECTED ON (B)(6) 2022. THE INFECTION HAS BEEN TREATED WITH INCISION, DRAINAGE. CONSEQUENCES; "LOST OF VOLUME", CHRONIC INFLAMMATION WITH PAIN.

Description of Event or Problem · 0

N/A.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1130752 INTEGRA¿ FLOWABLE WOUND MATRIX DERMAL REPAIR (SKIN) KGN INTEGRA LIFESCIENCES CORPORATION 5725546

Patients

Seq Age Sex Outcome Treatment
1 50 YR Male